Trending/MS
Study shows drug reduces risk of relapse with neuromyelitis optica
ROCHESTER, Minn. — The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder…
March 20, 2019
Infographic: Individualized treatment for multiple sclerosis
March 18, 2019
March 14, 2019
March 11, 2019
February 25, 2019
October 24, 2018
Special Topics
Sign up
Social Media Network
A network for digital healthcare communicators
Mayo Clinic Connect
An online patient support community